X
<

Stryker: Recent Developments and Analysts' Revisions

PART:
1 2 3 4
Part 4
Stryker: Recent Developments and Analysts' Revisions PART 4 OF 4

Stryker’s Recent Stock Price Movement: Upside Potential?

Stock performance

On November 29, 2017, Stryker (SYK) had a closing price of $154.1 per share. The stock has a 50-day moving average of $153.5, while the 200-day moving average for Stryker stock stands at $145.4. Stryker was trading at its 52-week high of $160.6 on October 27, 2017, due to investors’ positive sentiments. On October 26, 2017, the company reported strong earnings results for 3Q17. The actual results exceeded analysts’ estimates, as you can see in the following chart. Read Stryker Registers 52-Week High: What’s behind the Stock Rally? to learn more. Stryker registered 52-week low trading activity on December 1, 2017, when its stock traded at $110.9 per share.

Stryker&#8217;s Recent Stock Price Movement: Upside Potential?

Interested in SYK? Don't miss the next report.

Receive e-mail alerts for new research on SYK

Success! You are now receiving e-mail alerts for new research. A temporary password for your new Market Realist account has been sent to your e-mail address.

Success! has been added to your Ticker Alerts.

Success! has been added to your Ticker Alerts. Subscriptions can be managed in your user profile.

Stryker stock has registered slightly volatile activity in the past few months. However, the stock largely remains on a bullish trajectory. Stryker stock registered a fall of ~4% in its price on August 23, 2017. The company received an FDA warning that triggered a recall of certain products. There was also a downward revision to Stryker’s fiscal 2017 guidance. On November 28, 2017, Stryker stock registered a stock price gain due to a litigation settlement with Zimmer Biomet Holdings.

Comparison with peers and the industry

Since October 27, 2017, Stryker stock registered a fall of ~2.3%. In the last six months, Stryker’s stock return was ~9.1%. In the last three months, the stock has registered more than a 10% rise. The stock has returned ~22% in the last year—it has returned more than 38%. Stryker stock beat the market (represented by S&P 500 Index) and the industry average, which can be represented by the iShares U.S. Medical Devices ETF (IHI), by huge margins. The market and industry returns in the past year are reported to be 19.7% and 32%, respectively.

As of November 30, 2017, Stryker’s peers Medtronic (MDT), Becton Dickinson (BDX), and Zimmer Biomet Holdings (ZBH) have returned ~11.9%, 34.1%, and 8.9%, respectively, in the past 12 months.

X

Please select a profession that best describes you: